Our data suggest that SREBP1 promotes the expression of MMP7 by activating the phosphorylation of p65 and thus the NF-κB pathway, leading to an increase in the invasive capacity of intestinal cancer cells. The gene discussed is NFKB1; the disease is intestinal cancer.